ATTILI, ILARIA

ATTILI, ILARIA  

Università di Padova  

Mostra records
Risultati 1 - 13 di 13 (tempo di esecuzione: 0.02 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs? 2017 ATTILI, ILARIAPAVAN, ALBERTOCONTE, PIERFRANCOBonanno, Laura + CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - -
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer 2020 Zulato, ElisabettaAttili, IlariaPavan, AlbertoDel Bianco, PaolaBoscolo Bragadin, AndreaPasello, GiuliaFassan, MatteoCalabrese, FiorellaGuarneri, ValentinaAmadori, AlbertoConte, PierFrancoIndraccolo, StefanoBonanno, Laura + BRITISH JOURNAL OF CANCER - -
Immunotherapy in SCLC: Exceptional Clinical Benefit and Abscopal Pneumonitis After Radiotherapy 2019 Bonanno L.Attili I.Pasello G.Guarneri V. + JOURNAL OF THORACIC ONCOLOGY - -
Immunotherapy in small-cell lung cancer: From molecular promises to clinical challenges 2019 Pavan A.Attili I.Pasello G.Guarneri V.Conte P. F.Bonanno L. JOURNAL FOR IMMUNOTHERAPY OF CANCER - -
LKB1 and tumor metabolism: The interplay of immune and angiogenic microenvironment in lung cancer 2019 Bonanno L.Pavan A.Attili I.Pasello G.Conte P.Indraccolo S. + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors 2019 Pavan A.Dal Maso A.Attili I.Pasello G.Guarneri V.Conte P.Bonanno L. + THE ONCOLOGIST - -
Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome 2020 Zulato, ElisabettaFerro, AlessandraBoscolo, AliceAttili, IlariaFrega, StefanoDal Maso, AlessandroPasello, GiuliaGuarneri, ValentinaConte, Pier FrancoIndraccolo, StefanoBonanno, Laura + JOURNAL OF CLINICAL ONCOLOGY - -
Potentialities of liquid biopsy in advanced non-small cell lung cancer (aNSCLC): Early evaluation of sentinel mutations in plasma and outcome of patients treated with immunotherapy 2019 Bonanno, L.Zulato, E.Attili, I.Del Bianco, P.Nardo, G.Boscolo Bragadin, A.Pasqualini, L.Calabrese, F.Fassan, M.Pasello, G.Guarneri, V.Conte, P.Indraccolo, S. + ANNALS OF ONCOLOGY - -
Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancer 2020 Pasello G.Attili I.Bonanno L.Menis J.Conte P.Guarneri V. + CANCER TREATMENT REVIEWS - -
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome 2021 Boscolo Bragadin, AndreaZulato, ElisabettaAttili, IlariaDal Maso, AlessandroFrega, StefanoFassan, MatteoCalabrese, FiorellaPasello, GiuliaGuarneri, ValentinaConte, PierFrancoIndraccolo, StefanoBonanno, Laura + TRANSLATIONAL LUNG CANCER RESEARCH - -
SRC and PIM1 as potential co-targets to overcome resistance in MET deregulated non-small cell lung cancer 2020 Attili I.Bonanno L.Maso A. D.Fassan M.Pasello G.Guarneri V.Conte P. F. + TRANSLATIONAL LUNG CANCER RESEARCH - -
The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes 2018 Bonanno, L.PAVAN, ALBERTODieci, M. V.DI LISO, ELISABETTASchiavon, M.COMACCHIO, GIOVANNI MARIAATTILI, ILARIAPasello, G.Calabrese, F.Rea, F.Favaretto, A.Rugge, M.Guarneri, V.Fassan, M.Conte, P. F. EUROPEAN JOURNAL OF CANCER - -
Therapeutic approaches for T790M mutation positive non-small-cell lung cancer 2018 Attili, IlariaConte, PierFrancoBonanno, Laura + EXPERT REVIEW OF ANTICANCER THERAPY - -